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Abstract
McKimm, Eric. Ph.D. The University of Memphis. December 2016. Cerebellar Neuropathology
Influences Cerebellar-Prefrontal Cortex Pathways: A Comprehensive Approach as Relevant to
Autism Spectrum Disorders. Major Professor: Helen Sable, Ph.D.
The cognitive and social dexterity of humans is attributed to the neocortex, an area of the
brain well accepted to elevate us beyond the mental processing of all other species. The cognitive
ability of the cerebellum however, remains one of the most misunderstood. Autism spectrum
disorders (ASDs), with a prevalence of 1 in 68 children, lack clear empirical explanations for
abnormal neuropathology and potential neuronal disconnections influenced by the cerebellum.
The current evaluation takes a comprehensive look at how the cerebellum, pre-frontal cortex, and
basal ganglia are interconnected and influenced by each other as relevant to ASDs. With a better
understanding of deep cerebellar influence from the dentate nucleus (DN) evoking dopamine
release in the striatum, nucleus accumbens, and the medial prefrontal cortex (mPFC) allows for
better understanding of modulation of these nuclei. The studied nuclei have a great impact on
cognitions, reward systems, social and executive functions within both a typical developing brain
as well as the ASDs brain. The presence of null findings in the Fmr1 mouse when exploring
aspects of the striatum and accumbens are contrary to previous evidence showing DN
modulation via the ventral tegmental area (VTA), however it notes the importance of exploring
the same research paradigm within the Lurcher mouse strain to explore differences in Purkinje
cell dysfunction as compared to absence. Interestingly two forms of compensation where
observed in the Lurcher mutant strain in mPFC dopamine release via the VTA and the
mediodorsal thalamus (ThN md) with a shift in strength towards the mutant strain within the
VTA, and contrarily a shift in strength towards the wildtype strain in the ThN md, with null
findings in the ventrolateral thalamus (ThN vl). These results lend further support to the Autism
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disconnection hypothesis that there is in some form an attenuation between the DN and the
mPFC via a variety of nuclei. The current findings can inform future directions that include
potential treatment interventions by means of a variety of therapeutic techniques including deep
brain stimulation, pharmaceutical approaches, viral vectors and others, to alleviate some of the
debilitating symptoms of ASDs.

iv

Preface
This dissertation has been formatted to allow for the separate publication of Chapters 3,
and 4. As such, these chapters have been formatted according to the style guidelines of the
journals to which each has been or will be submitted.
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Chapter 1
Cerebellar Influence on Forebrain and Midbrain Nuclei as Relevant to Autism Spectrum
Disorders
Autism Spectrum Disorders
Autism spectrum disorders (ASDs) are neurodevelopmental disorders that traditionally
encompass autism, Asperger’s syndrome and pervasive developmental disorders not otherwise
specified (APA, 2013). Autism is characterized by deficits in social skills and communication,
unusual and repetitive behaviors as well as deficits in cognitive function (APA, 2013). Deficits
of cognitive function include impairment in memory and attention, cognitive flexibility, abstract
thinking, rule acquisition, and others (Ozonoff, South, & Provencal, 2007). Individuals with
autism often exhibit motor deficits consisting of slow and repetitive hand and foot movements
(Dowell, Mahone, & Mostofsky, 2009), slow and inaccurate dexterity (Green et al. 2002),
unstable balance (Freitag, Kleser, Schneider, & von Gontard, 2007), and impaired gait
(Jansiewicz et al. 2006). The motor and cognitive deficits appear to have some relation in autism,
as better motor skills are positively correlated with better daily living skills (Jasmin et al. 2009).
Learning deficits manifest in individuals with autism, but appear to be specific to social as
opposed to non-social rewards. For example, Lin et al. (2012) showed that ASDs individuals
exhibited greater behavioral insensitivity to a social reward of positive or negative faces, as
compared to a token reward of winning or losing money. Impaired social reward processing is
also present in individuals with autism when trying to orient to naturally occurring social stimuli
in various gaze orientation studies (Dawson et al. 1998, Klin et al. 2009). The specific etiology
of these deficits in ASDs remain unknown, however studies have linked genetic proclivities,

1

viral infections, toxins, and developmental abnormalities to the formulation of ASDs (Rogers et
al., 2013b).
Developmental Pathologies in ASDs
Brain development in ASDs produce a multitude of functional errors at the genetic,
molecular, and systems levels. Locating the most frequently occurring pathologies is a promising
route for tracing back the origin of abnormal development. Despite varying predispositions to
the development of ASDs, cerebellar neuropathology consisting of cerebellar hypoplasia and
reduced Purkinje cell numbers appears to be one of the largest neurological commonalities
(Courchesne, Yeung-Courchesne, Press, Hesselink, & Jemigan, 1988; Bauman, 1991;
Courchesne et al., 1994; Palmen, Van Engeland, Hof & Schmitz, 2004; Courchesne, 1997;
DiCicco et al., 2006; Whitney, Kemper, Bauman, Rosene, & Blatt, 2008). This reduction in
Purkinje cells is also present in other disorders on the autism spectrum, including Asperger’s and
other syndromes (Murakami, Courchesne Haas, Press, & Yueng-Courchesne, 1992; McKelvey,
Lambert, Mottron, & Shevell, 1995; Hallahan et al., 2009). Due to this neuronal commonality in
cerebellar Purkinje cell loss or dysfunction in a myriad of psychiatric disorders, specifically
ASDs, their influence will be the primary focus of the current studies.
Traditionally the cerebellum has been known for movement coordination. However,
recent studies show evidence of the cerebellum’s influence on cognition, specifically emotion
regulation and social cognition, mental flexibilities, spatial organization, linguistic processing;
cognitions that are influential in disorders including ASDs, mood disorders, attention deficit and
other psychiatric disorders (Shakiba, 2014; Fatemi, & Folsom, 2014; Wang, Kloth, & Badura,
2014). Magnetic resonance imaging (MRI) scans show evidence that children with autism have
decreased cerebellar volume as compared to a healthy child (Webb et al., 2009). MRI scans
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revealed structural abnormalities in the frontal lobe, the extent correlated to the degree of
cerebellar abnormality (Carper & Courchesne, 2000; Limperopoulos et al., 2012). Individuals
with autism also showed low medial prefrontal cortex (mPFC) dopaminergic activity compared
to age and gender matched controls (Ernst et al., 1997). The relationship between cerebellar and
frontal abnormalities suggests that these pathologies may be causally linked. Following this
notion, postmortem studies show clear reductions in the size and number of cells in the deep
cerebellar nuclei, the dentate nucleus (DN), an area commonly associated with cognitive
function, and which acts as the largest intermediary link between the cerebellum and the rest of
the brain (Bailey et al., 1998; Bauman & Kemper, 2005; Vargas, Nascimbene, Krishnan,
Zimmerman, & Pardo, 2005). It is widely accepted that increased neocortical complexity and
volume in humans is associated with higher intellectual capacity, but little has been mentioned
about the role of the cerebellar DN in organizing this complexity during development. Only
recently has it been shown that the elaborate folding and increased surface area of the dentate
nucleus is associated with the development of the finer topographic mapping of connections
between the cerebellar cortex and the DN (Sultan, Hamodeh & Baizer, 2010). Also, input from
the cerebral cortex to the cerebellum is attributable to various types of nuclei (visual, spatial,
premotor, motor), but complex synchronization and funneling of information allows Purkinje
cells to provide the sole source of output from the cerebellar cortex, via activity on the DN
(Voogd & Glickstein, 1998). Due to the GABAergic (γ-aminobutyric acid containing) nature of
these neurons, Purkinje cells use inhibition to shape the spatiotemporal patterns of electrical and
chemical signaling throughout the entire brain, and investigations of feed-forward neural
networks suggest that a single Purkinje cell can retain up to 40,000 input-output associations
(Brunel, Hakim, Isope, Nadal, & Barbour, 2004; Huang, Di Cristo, & Ango 2007). This
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combined information leads to the assumption that pathology of the cerebellum is causing a
detrimental influence on the frontal lobe during development, particularly the prefrontal cortex
(PFC), and marks the Purkinje cells as a prime site for investigation.
In addition to the relation between Purkinje cells and cognition, their role in integrating
and sharpening the dynamics of motor movement is well known (Klein, 1995; Thoroughman &
Shadmehr, 2000). Interestingly, in ASDs, degree of motor skill dysfunction has been shown to be
predictive of degree of autistic symptomology in later life, suggesting an interrelation between
motor and cognitive deficiencies (Sutera et al., 2007). With the recent understanding that
cerebellar hemispheres are connected via the ventrolateral thalamus with contralateral associative
(prefrontal, parietal, temporal cortices) areas in the brain, this supports the notion that deficits in
Purkinje cells may contribute simultaneously to malfunctions in motor skills and cognitive
processes in ASD (Palesi et al., 2015). Modulation of cerebellar Purkinje cell output may serve
as the starting point of this interrelation, but locating affected downstream pathways that
modulate both motor movement and cognition is still in its earliest stages (Ciesielski & Knight,
1994).
Purkinje cells in the cerebellum send information to the mossy fibers (MF) of neurons in
the pontine nuclei, which then project contralaterally to the cerebellar cortex ultimately
terminating on granule cells (Weschler-Reva & Scott, 1999). Granule cells transfer contextual
information from MFs through excitatory signals of parallel fibers that facilitate learning in
Purkinje cells, ultimately stimulating signal output from the deep cerebellar nucleus (Voogd &
Glickstein, 1998; Philipona & Oliver, 2004). Functionality of Purkinje cells located within the
deep cerebellar nucleus systemically influences a variety of sensory association and motor
cortices of the parietal and frontal lobes. These associations have always been clearly associated
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with fine motor skills and movement, however recently evidence of cognitive influences in the
prefrontal cortex and the specific nuclei along the cerebellar-PFC pathways has been discovered
(Rogers et al., 2013b). This has intuitively raised many questions of a cerebellar role in higher
cognitive processes.
Autism Disconnection Hypothesis
All of the previously mentioned findings provide an ideal framework to probe this notion
of cerebellar modulation of cognition, and give strong support for the autism disconnection
hypothesis; that there is some form of a division in the autistic brain due to cerebellar
neuropathology and more specifically due to a reduction in or function of Purkinje cells (Palmen
et al., 2004; Whitney et al., 2008; Amaral, Schumann, & Nordahl, 2008). The disconnection
hypothesis implies that the etiology of any given disorder can be attributed to a loss of
connectivity between two or more brain regions (Catani & Ffytch, 2008). Traditionally this
theory pertained to traumatic severances of circuitry, currently it encompasses both
developmental neuropathology as well as disturbances in, or dysregulation of, neural circuitry
producing impaired functional circuitry (Geschwind, 1965; Geshwind & Levitt, 2007). Potential
disconnections within the autistic brain could manifest initially from potential developmental
disturbances ultimately compounding in compensations and adaptations of the affected neuronal
circuitry.
The currently explored cerebello-cortical projections may be responsible for many of the
cognitive, social and motor reward symptomatology present in individuals with autism. The
pathway explored originates in the DN and terminates in the medial prefrontal cortex (mPFC)
with a variety of nuclei interconnected along the way. Currently there are two distinct pathways
that originate in the DN and terminate in the prefrontal cortex. Previous research shows that the
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cerebellum projects, via the thalamus, to areas 9, 46, and 91 of the PFC known to be involved in
cognitive functions related to memory, planning, and decision making (Middleton & Strick,
2000; Schmahmann, 2001). DA release in the mPFC may be mediated by deep cerebellar
glutamatergic projections to the thalamic nuclei that ultimately terminate in the mPFC.
Middleton and Strick have also shown in Cebus monkeys that cerebellar projections to
prefrontal, oculomotor, and skeletomotor areas of the cortex, primarily influencing dorsal regions
while avoiding ventral regions of the PFC via contralateral thalamic nuclei, originate in distinct
regions of the ventral DN (1997, 2001). Erickson and colleagues found similar findings of DN to
thalamic projections in Cynomolgus monkeys (2004). The striatum within the nigrostriatal
pathway is associated with reward and inhibition processing, as well as motor programs that are
conducive in reward-seeking behavior (Kravitz & Kreitzer, 2012). Spiny neurons of the
dorsomedial striatum (DMS) provide both excitatory and inhibitory influences within the basal
ganglia of D1 and D2 receptors. Influences that show connections to the associative cortex as
well as the hippocampus, amygdala, PFC, and thalamus (Graybiel, Aosaki, Flaherty, & Kimura,
1994), all areas associated with goal-directed behaviors and executive functioning, which are
deficient in individuals with autism (Da Cunha, Gomex, & Blaha, 2012). Jayaraman (1985) has
shown striatal connectivity with the most medial, ventrolateral and medial-lateral thalamic
nuclei, implicating possible influences of disconnection of DN to striatal pathways similar to
those previously seen along the DN-thalamic-PFC pathway.
A second cerebellum-PFC circuit that may influence cognitive functions projects
indirectly through the ventral tegmental area (VTA). The VTA contains dopamine (DA) cell
bodies comprising the mesocortical dopaminergic systems that ultimately terminate in the PFC
(Fallon & Moore, 1978). Within the second cerebellar-PFC circuit, the DN and the interpositus
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nucleus both have excitatory glutamatergic neurons that send contralateral projections to the
reticulo-tegmental nuclei of the pons (RTN) in a topographic manner (Angaut et al., 1985;
Torigoe et al., 1986; Schwarz and Schmitz 1997; Teune et al., 2000). The RTN sends rostral
neuronal projections to the pedunculopontine tegmental nuclei (PPT), providing reciprocal
projections back to the RTN (Vertes et al., 1986; Reese et al., 1995; Garcia-Rill et al., 2001).
Excitatory cholinergic and glutamatergic neurons, encompassing glutamate and acetylcholine,
within the rostral and caudal aspects of the PPT project to DA-containing cells within the VTA
and substantia nigra compacta (SNc) (Lavoie & Parent, 1994; Oakmen et al., 1995, 1999).
Electrophysiological studies have shown RTN neurons respond to prolonged spiking activity, up
to 12s, from stimulation in the PPT (Garcia-Rill et al., 2001). This sustained activity of neurons
in the RTN reciprocally sustain activation of PPT glutamatergic/cholinergic afferents to
dopaminergic cells in the VTA and SNc. These findings are consistent with those displaying
electrical stimulation of the PPT effectively enhances neurotransmission in both the mesocortical
and nigrostriatal dopaminergic systems (Blaha & Winn, 1993; Blaha et al., 1996, Forster et al.,
2002; Forster & Blaha, 2003). Perciavalle and colleagues (1989) have shown that the DN, and to
a lesser extent the interpositus nucleus in the rat, may exhibit direct contralateral projections to
the VTA and the dorsal aspects of the SNc, midbrain regions containing a high density of
dopaminergic cells. Due to this, it is possible that direct circuits, such as DN → PPT → VTA or
DN → PPT, may modulate mesocortical dopaminergic cell activity. The nucleus accumbens
(NAc) within the mesolimbic pathway exhibits functionality with reward processing as well as
social activation and inhibition. Projections from the basal ganglia to midbrain DA neurons in
the pedunculopontine and striatum (specifically the caudate nucleus, putamen, and nucleus
accumbens core (NAcc)) have been closely linked to non-motor, cognitive and reward

7

functioning (Schultz, 2016). Social interaction and play is closely linked to reward-oriented
behavior due to the satiable interpersonal response received from such interactions. It has been
shown that DA neurotransmission in the NAcc can influence social play in rats (Maduca et al.,
2016), ultimately playing a modulatory role in social interaction based on the level of DA present
in the NAcc. Social interaction is directly correlated with the concentration of DA, and
ultimately linked to reward seeking behavior commonly associated with both the striatum and
the NAcc. Impairment of reward functioning and social deficits are common in individuals with
autism. Lack of cognitions such as theory of mind, detection, interpretation, and execution of
appropriate social cues are some of the most common observable symptoms of autism. Any
potential deficiencies of DA transmission due to Purkinje cell dysfunction from the DN make the
DMS and NAcc viable nuclei to explore in the current study.
Previous studies show a clear delineation that the DN → mPFC projections are split
approximately 50:50 between the VTA and dorsomedial and ventrolateral thalamic nuclei
(Rogers et al., 2013a, 2013b). Additionally, research has shown aberrant striatal functionality
and connectivity within the anterior cingulate and frontal cortex, orbitofrontal cortex, and the
brain stem (Di Martino et al., 2011). This could be closely linked to the evidence of attenuation
and reorganization of cerebellar modulation in DA release in the PFC of Lurcher mutant and
Fmr1 KO mice (rodent models that exhibit dysfunction or absence of Purkinje cellular influence
in the cerebellum), along the ventral tegmental area (VTA) and thalamic pathways, which
originate in the DN (Mittleman et al. 2008; Rogers et al., 2011, 2013a). As seen, Purkinje cell
number and cerebellar modulation poses a great influence on the DN to mPFC pathway
ultimately eliciting mPFC DA release. With the extensive complexity of afferent connections
from the cerebellum to nearly all major neural systems in the brain, it is important to understand
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the functional interactions and adaptations within this circuitry. The current circuitry, based on
previous and current findings, by which the cerebellum modulates the frontal cortex,
mesocortical and nigrostriatal dopaminergic pathways are depicted in Figure 1.

Figure 1. Representative diagram of explored neural circuitry in current studies. Dentate (DN)
influence on prefrontal cortex (PFC), striatum and nucleus accumbens (NAc) dopamine release.
RTN: reticulotegmental nucleus, PPT: pedunculopontine tegmentum, VTA: ventral tegmental
nucleus, SN: substantia nigra, mPFC: prefrontal cortex. Excitatory (glutamatergic) – red lines;
dopaminergic – green lines.
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Rodent Models with Cerebellar Abnormalities
Cerebellar neuropathology is explicitly related to autism (Courchesne et al., 1988). The
basis of the current and previous research that cerebellar neuropathology influences an array of
nuclei throughout the brain makes rodent models with cerebellar abnormalities appropriate for
exploration. However, no current model can holistically mimic an individual with autism’s
neuronal structure, and even more difficult is representing environmental influences experienced
through development or other etiological factors of the disorder. Two models studied in the
current research setting, were the Fmr1 knockout mouse and the Lurcher mutant mouse, as well
as their wildtype control counterparts. While the two models used are not explicitly models of
autism, they are particularly appropriate due to their cerebellar neuropathology. This project uses
simplified models, including the Fmr1 and even more so the Lurcher, to start at a fundamental
level of neuropathology for exploration. As autism is a multi-faceted disorder containing
cognitive deficits, social and reward processing impairments, movement aberrations, as well as
other symptomatology, it was critical to utilize a range of appropriate rodent models.
Fmr1 knockout mouse. The Fmr1 mouse is a model of fragile X syndrome which is a
form of intellectual disability. Fragile-X syndrome is the most common monogenetic cause of
autism, stemming from the silencing of the FMRP gene (El Idrissi et al., 2005). Patients with
fragile X syndrome display autism-like cognitive symptoms and have an increased probability of
an autism diagnosis (Rogers, Wehner, & Hagerman, 2001; Tsiouris & Brown, 2004). The Fmr1
mice present with similar symptomatology as seen in autism such as hyperactivity, decreased
spatial learning abilities, memory deficiencies, reduced fear conditioning, and perseverative
behaviors (Bernardet & Crusio, 2006; Ey & Bourgeron, 2011; Olmos-Serrano, Corbin, & Burns
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2011). Fmr1 knockouts (KO) display cerebellar abnormalities such as elongated Purkinje cell
spines and decreased volume of cerebellar nuclei (Koekkoek et al., 2005; Ellegood et al., 2010).
Fmr1 knockouts have an Fmr1tm1Cgr targeted mutation and are widely used as a mouse model of
Fragile X syndrome (Verkerk et al. 1991; Goodrich-Hunsaker et al. 2011).
Lurcher mutant mice. Lurcher mutant mice have an autosomal dominant mutation that
results in nearly a complete loss of Purkinje cells between the 2nd and 4th weeks of life (Caddy &
Biscoe, 1979; Zuo et al., 1997). The origin of the Lurcher name is due to the ataxic and distinct
‘lurching’ movements made by these mice. Due to the exaggeration of Purkinje cell loss in the
Lurcher model, they are often coupled with chimeras, which have a variable loss of Purkinje
cells based on their coupling with the wildtype lineage. Beyond the movement deficits, Lurchers
and chimeras present impaired executive functioning as measured by a battery of serial reversal
tasks in which learning errors were negatively correlated with Purkinje cell counts (Dickson et
al., 2010). Negative correlations were also found between repetitive behaviors and cerebellar
Purkinje cell number in chimeras, Lurchers also displayed memory deficits in maze tasks (
Belzung, Chapillon, & Lalonde, 2001; Martin, Goldowitz, & Mittleman, 2010). The Lurcher
mouse exhibits debilitated executive functions and repetitive behavioral abnormalities directly
related to cerebellar Purkinje cell numbers, a neuronal commonality observed in ASDs.
There are a variety of constraints within all currently accepted models of cerebellar
neuropathology for application as an autism model. The Fmr1 and Lurcher models are not
explicitly designed to be a model of autism, but are two of the most appropriate, due to the
elongation of, Fmr1 KO, and absence of, Lurcher, cerebellar Purkinje cells. Purkinje cells are
believed to manifest the abnormal neuropathology in the DN that elicits many of the symptoms
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present in ASDs. The benefit of the current research is much of the same methodology and
experimental designs are performed in both the KO and Lurcher mouse strains.
Summary and Conclusions
ASDs are multifaceted disorders, much of what is still not understood or misunderstood.
What makes understanding these disorders particularly pressing is the alarming increase in
incidence rates, with increases in new diagnoses from 6-15% each year from 2002 to 2012
(CDC, 2016). Rodent models that anatomically mimic neuropathological abnormalities
commonly seen in autism provide a good experimental platform for trying to understand the
neurological pathways involved in autism. Previous research, both clinical and experimental,
shows the influence of cerebellar damage on developmental deficiencies in autism, specifically
the effects of Purkinje cellular influence on the DN. Both mouse models currently being used,
Fmr1 and Lurcher, exhibit deficiencies of Purkinje cells in the cerebellum, informing how
absence and/or dysfunction of these cells directly influences the cognitive, social, and motor
reward centers, as well as other advanced executive functions in the frontal cortex and basal
ganglia.
Continued research of the current explored pathways from the cerebellum to the PFC on
the effects of glutamatergic and dopaminergic release is important both clinically and
experimentally. The anatomical and physiological understandings of the DN-thalamic-PFC, the
DN-VTA-PFC (with branches off to the NAc and striatum pathways), need further exploration to
couple the current findings of cerebellar modulation on PFC DA release, with deficits in
executive functioning. As various nuclei, both glutamatergic and dopaminergic, along the
explored pathways are better understood it allows for experimental manipulation and ultimately
clinical trials to see the direct effects of manipulation of the neurochemical imbalance due to
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anatomical abnormalities. As we will see in the current research, the mouse brain already makes
compensatory mechanistic attempts to account for such aberrations. The natural compensation
could easily be coupled with a pharmaceutical approach, use of viral vectors to selectively alter
nuclei, introduction of new genetic material, or deep brain stimulation methods. Any and all of
these could provide us with an understanding of the behavioral and cognitive consequences of
this neurochemical imbalance due to cerebellar deficits in the autistic brain.
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Chapter 2
Fixed Potential Amperometry Methodology
Electrochemical Recording Electrodes Used in FPA
The experimental studies in Chapters 3 and 4 utilize in vivo fixed potential amperometry
(FPA). FPA is an electrochemical technique used to detect the release of oxidizable
neurotransmitters by use of a three-electrode configuration that incorporates an auxiliary
electrode, reference electrode, and a recording electrode (see Figure 1) (Blaha & Phillips, 1996).
FPA coupled with carbon-fiber DA recording microelectrodes has been shown to be a valid
technique for real-time monitoring of stimulation-evoked DA release (Forster & Blaha, 2003;
Agnesi et al., 2009; Agnesi, Blaha, Lin & Lee, 2010). Amperometric recordings are done within
a Faraday cage to increase the signal to noise ratio and eliminate static interference (Forester &
Blaha, 2003). For purposes of the experiments performed in Chapters 3 and 4, FPA was used
with a concentric bipolar stimulating electrode (SNE-100, Kopf Instruments), a carbon-fiber
microelectrode (DA recording electrode; carbon fiber 10 µm o.d., 250 µm length, Thornel Type
P, Union Carbide, Bristol, PA, USA), and an Ag/AgCl reference/auxiliary (stainless steel 30g
wire) electrode combination. Following implantation of all electrodes a fixed positive potential
(+0.8 V) was applied to the recording electrode and oxidation current, reflective of DA
concentrations, measured continuously via the recording electrode (10 K samples/s) via an
electrometer (ED401 e-corder 401 and EA162 Picostat, eDAQ Inc., Colorado Springs, CO,
USA) filtered at 10 Hz low pass. A total of 15 stimulations (50 monophasic 0.5 ms duration
pulses at 50 Hz every 60 s) were applied to the DN (at 800 µAmps) via the stimulating electrode
with use of an optical isolator and programmable pulse generator (Iso-Flex/Master-8; AMPI,
Jerusalem, Israel). Electrochemical techniques generally have lower chemical selectivity,
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however pharmacological studies have validated the selectivity of FPA, and have been
specifically demonstrated by significant increases in Purkinje cell layer stimulation-evoked
oxidation current in the mPFC following systemic influence of the DA reuptake inhibitor
nomifensine. No evidence of increased oxidation current following serotonin and norepinephrine
reuptake blocker with fluoxetine and desipramine, respectively was observed (Dugast et al.,
1994; Forster & Blaha, 2003; Mittleman et al., 2008).

Figure 1. Simplified diagram of three-electrode system used in chronoamperometry
electrochemical recordings. An electrical potential is applied to the auxiliary (AUX) electrode
via the electrometer, allowing it to oxidize dopamine (DA) on the surface of the carbon-fiber DA
recording microelectrode (RE), held in fixed potential (+0.8 V) relative to the reference electrode
(REF). Oxidized dopamine current measured via an electrometer and transferred to the chart
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recorder (ED401 e-corder 401 and EA162 Picostat, eDAQ Inc., Colorado Springs, CO, USA)
filtered at 10 Hz low pass. Chart software (eDAQ v5.2) displaying near real time digital signal.
Adapted from Blaha & Phillips (1996) and Rogers (2013b).
Stereotaxic Surgery and Recording Set-up for FPA
All mice were urethane-anesthetized (1.5 g/kg i.p.) and placed in a stereotaxic frame
(David Kopf Instruments, Tujunga, CA, USA). Body temperature was maintained at 36±0.5 °C
with a temperature-regulated heating pad. In individual mice in Chapter 3, the stimulating
electrode was implanted to site ipsilateral to the recording electrode implanted in the left
hemisphere, while the reference/auxiliary electrode was implanted contralateral and anterior to
the stimulating electrode onto the surface of the cortex (see Figure 2). In individual mice in
Chapter 4, the stimulating electrode was implanted to site contralateral to the recording electrode
implanted in the left hemisphere, while the reference/auxiliary electrode was implanted
ipsilateral and anterior to the stimulating electrode onto the surface of the cortex (see Figure 3).
Stimulating and recording electrodes were implanted based on coordinates with respect to
bregma and depth with respect to dura (Paxinos & Franklin, 2001).
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Figure 2. Schematic diagram of the mouse brain illustrating a typical setup for in vivo fixed
potential amperometric recording of stimulation-evoked dopamine release. In the experiments in
Chapter 3, a carbon-fiber recording electrode was positioned in either the striatum or accumbens.
A stimulating electrode was positioned in cerebellar dentate nucleus (DN). A silver/silver
chloride reference and stainless-steel auxiliary electrode combination was placed in contact with
contralateral cortical tissue. Inhibitory (GABAergic) – blue line; excitatory (glutamatergic) – red
lines; dopaminergic – green lines.
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Figure 3. Schematic diagram of the mouse brain illustrating a typical setup for in vivo fixed
potential amperometric recording of stimulation-evoked medial prefrontal cortex (mPFC)
dopamine release. In the experiments in Chapter 4, a carbon-fiber recording electrode was
positioned in either the medial prefrontal cortex (mPFC). A stimulating electrode was positioned
in the ventral tegmental area (VTA), the mediodorsal thalamic nuclei (md ThN), or the
ventrolateral thalamic nuclei (vl ThN). A silver/silver chloride reference and stainless-steel
auxiliary electrode combination was placed in contact with contralateral cortical tissue.
Inhibitory (GABAergic) – blue line; excitatory (glutamatergic) – red lines; dopaminergic – green
lines.
Post-Experimental Procedures
Immediately following each experiment, a direct current (100 µA for 10s; +5 V for 5 s)
was passed through the stimulating electrode in the DN and through the recording electrode in
either the mPFC, NAcc or DMS to lesion tissue, respectively. Each mouse was euthanized with a
lethal intracardial injection of urethane. Brains were removed and preserved overnight in 10%
buffered formalin containing 0.1 % potassium ferricyanide, and then stored in 30 % sucrose/10
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% formalin solution until sectioning. At the conclusion of the experiment brains were sectioned
on a cryostat at -30 ̊C. A Prussian blue spot indicative of the redox reaction of ferricyanide and
iron deposits labeled the stimulating electrode in the DN, and the electrolytic lesion determined
the location of the recording probe. All placements were noted on representative coronal
diagrams (Paxinos & Franklin, 2001).
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Chapter 3
Purkinje Cellular Neuropathology Does Not Influence Nucleus Accumbens or Striatal
Dopamine Release: Relevance to Autism Spectrum Disorders
Introduction
The cognitive and social dexterity of humans is attributed to the neocortex, an area of the
brain thought to elevate us beyond the mental processing of all other species (Rakik, 2009).
However, the pathological characteristics seen in individuals with autism spectrum disorders
(ASDs) propose a different narrative. Autism spectrum disorders are neurodevelopmental
disorders that traditionally encompass autism, Asperger’s syndrome and pervasive
developmental disorders not otherwise specified (APA, 2013). Motor and cognitive deficits are
correlated with quality of life and better daily living skills in individuals with autism (Jasmin et
al., 2009). Social interaction cues and rewards are often more deficient in individuals with
Autism as compared to token and non-social rewards (Lin et al., 2012). The targets of the current
study, the nucleus accumbens and striatum, play critical roles in both reward and reinforcement
properties of the brain, as well as movement response and reward.
The cerebellum traditionally has been primarily known for movement and coordination.
However, recent evidence has shown the cerebellum’s influence on cognition, emotion
regulation, and social processing; cognitions that are often influenced or deficient in disorders
including ASDs, mood disorders, attention deficits, and other psychiatric disorders (Shakiba,
2014; Fatemi, & Folsom, 2014; Wang, Kloth, & Badura, 2014). Structural abnormalities within
the dentate nucleus (DN) of the cerebellum are the most common neuronal abnormalities in
individuals with ASDs, specifically reduction in Purkinje cells (Murakami, Courchesne Haas,
Press, & Yueng-Courchesne, 1992; McKelvey, Lambert, Mottron, & Shevell, 1995; Hallahan et

32

al., 2009). Purkinje cells are closely related to cognition associated with the cerebellum, as well
as integration and dexterity of motor movements (Klein, 1995; Thoroughman & Shadmehr,
2000).
All of the previously mentioned findings provide an ideal framework to probe this notion
of cerebellar modulation of cognition, and give strong support for the autism disconnection
hypothesis that there is some form of a division in the autistic brain due to cerebellar
neuropathology, and more specifically due to a reduction in or function of Purkinje cells (Palmen
et al., 2004; Whitney et al., 2008; Amaral, Schumann, & Nordahl, 2008).
Abnormal Circuitry in ASDs
Cerebello-cortical interactions during critical periods of development have been proposed
as a probable culprit of executive function loss, contributing to the core symptoms in ASDs
(Fatemi et al., 2012). Recent in vivo neurochemical recordings of mouse strains used to model
autism were used to map these interactions, showing Purkinje cells regulate dopaminergic
activity via projections from the DN to cognitive centers in the brain, specifically the mPFC,
eliciting an unusual reorganization of mediating pathways. Specifically, Mittleman et al. (2008)
used DN electrical stimulation to evoke dopamine (DA) efflux in the mPFC of Lurcher mutant
mice (a model of olivopontocerebellar neurodegeneration with complete loss of Purkinje cells
occurring within the first four weeks of life) and compared their responses to Lurcher wildtype
control mice with normal Purkinje cell numbers. The Lurcher strain is a less commonly used
model of ASDs due to its extreme loss of Purkinje cells, however it is an acceptable model due
to the parallels in cerebellar pathology between the strain and individuals with autism. The
Lurcher mutants exhibited attenuation in mPFC DA release when compared to controls. This
suggests that developmental loss of Purkinje cells, similar to observations in ASDs, can lead to a
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disruption in mPFC DA modulation. However, the relay nuclei involved in this disruption
remain unclear.
Rogers et al. (2013a) expanded on the research of Mittleman and colleagues by
comparing cerebellar modulation of dopaminergic mPFC release in the Lurcher and Fmr1
Knockout (KO; a mouse model of Fragile-X syndrome) mouse strains to their respective
wildtype controls. The results unveiled a reorganization of mediating neuronal pathways
projecting to the mPFC. In this study, infusions of the sodium channel blocker lidocaine or the
glutamate receptor antagonist kynurenate were used to inactivate dopaminergic and
glutamatergic neuronal bodies (ventral tegmental area, thalamic mediodorsal, or thalamic
ventrolateral), respectively, to compare functional adaptations of cerebello-cortico circuitry
associated with abnormalities in cerebellar functioning. An attenuation of cerebellar-mPFC DA
release in both mutant mice strains was found, along with a shift in strength of dopamine signal
modulation towards the thalamic ventrolateral nuclei (ThN vl). Additionally, this research
unveiled a shift away from the ventral tegmental pathway, while inactivation of the mediodorsal
thalamic nuclei (ThN md) did not significantly alter DA release in either strain.
A shift in modulatory strength towards the ThN vl, whether an adaptive or maladaptive
shift, is an important finding to note due to its known projections to the dorsal striatum (DS). The
DS is the major input station of the basal ganglia and is directly involved in regulation of the
corticostriatal loops (Jayaraman, 1985; McFarland & Haber, 2010). The thalamus also mediates
activity in these cortico striatal circuits. As noted earlier, individuals with ASD show
impairments in rule acquisition, specifically the ability to abstract a novel task and associate it
with reinforcement (Dawson, Meltzoff, Osterling, & Rinaldi 1998; Ozonoff, 2007). This taken
together with the reported reconfiguration of DA and glutamate pathways toward the ThN vl
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exposes a paramount explanation of the reward, motor, and executive functioning deficits
observed in ASDs. Rule learning tasks have substantial dependence on activation of the
prefrontal cortex, striatum, and premotor and motor cortices, and research has been presented
showing cerebellar modulation of the prefrontal cortex via the thalamic nuclei (Toni, Rowe,
Stephan, & Passingham, 2002; Bunge et al., 2005). With the striatum being functionally
hyperconnected to many nuclei (subcortical and cortical) in ASDs and receiving an input from
nearly all cortical and subcortical areas, this shift in cerebellar modulation towards the ThN vl
leads to speculation of the cerebellum’s influence on not only the prefrontal cortex, but also the
nigrostriatal and mesolimbic pathways (Di Martino et al., 2011). In essence, the cerebellum
seems to be an information processor that uses the basal ganglia to filter relevant data for actionselection, and the prefrontal cortex as a means to mentalize and choose the best behavioral
response via the corticostriatal loops. Thus, Purkinje cell loss or developmental malfunction has
the potential to disrupt all major forms of neural processing (visual, motor, executive, and
motivational) through abnormal spatiotemporal signaling throughout the entire cortical and
subcortical cerebrum.
As noted, it has been previously shown that individuals with Autism exhibit motor and
reward deficits that often coincide with cognitive and executive functioning deficits. As seen,
Purkinje cell number and cerebellar modulation poses a great influence on the DN to mPFC
pathway ultimately eliciting mPFC DA release. However, little has been shown with regards to
these potential cerebellar deficits and their effect on any potential modulation of the nigrostriatal
and mesolimbic DA projections. This was the purpose of the current study, to see relative release
and magnitude of dopamine along the cerebellar to nigrostriatal and mesolimbic dopamine
pathways in the Fmr1 wildtype and Fmr1 KO mice. Stimulation-evoked dopamine release was
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monitored in the striatum and NAcc using the same methods as used in previous DN-mPFC
studies (Rogers et al., 2013a, 2013b). Comparison between the Fmr1 wildtype control and
experimental mutant Fmr1 KO mice allows for exploration of the potential effects of the
elongation and dysfunction of cerebellar Purkinje cells. With the extensive complexity of
afferent connections from the cerebellum to nearly all major neural systems in the brain, it is
important to understand the functional interactions and adaptations within this circuitry.
Ultimately exploring these neural substrates and associated receptor mechanisms has allowed for
a deeper understanding of the cognitive and motor deficits related to ASD.
Current Explored Pathways
The striatum within the nigrostriatal pathway was explored due to its functionality
associated with reward and inhibition processing, as well as motor programs that are conducive
in reward-seeking behavior (Kravitz & Kreitzer, 2012). Spiny neurons of the dorsal striatum
provide both excitatory and inhibitory influences within the basal ganglia of D1 and D2
receptors, influences that show connections to the associative cortex as well as the hippocampus,
amygdala, prefrontal cortex, and thalamus (Graybiel, Aosaki, Flaherty, & Kimura, 1994), all
areas associated with goal-directed behaviors, as well as executive functioning (Da Cunha,
Gomex & Blaha, 2012); executive functioning that is dysfunctional in individuals with autism.
Jayaraman (1985) has shown striatal connectivity with the most medial, ventrolateral and
medial-lateral thalamic nuclei, implicating possible influences of disconnection of dentate to
striatal pathways similar to those previously seen along the dentate-thalamic-PFC pathway.
The nucleus accumbens within the mesolimbic pathway was explored due to its
functionality with reward processing as well as social activation and inhibition. Projections from
the basal ganglia to midbrain DA neurons in the pedunculopontine and striatum (specifically the
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caudate nucleus, putamen and nucleus accumbens) have been closely linked to non-motor,
cognitive and reward functioning (Schultz, 2016). Social interaction and play is closely linked to
reward-oriented behavior due to the satiable interpersonal response received from such
interactions. It has been shown that DA neurotransmission in the NAc can influence social play
in rats (Maduca et al., 2016), ultimately playing a modulatory role in social interaction based on
the level of DA present in the NAc. Social interaction is directly correlated with the
concentration of DA, ultimately linking to reward-seeking behavior commonly associated with
both the striatum and the NAc. Impairment of reward functioning as well as social deficits are
commonalities in individuals with autism. Lack of cognitions such as theory of mind, detection,
interpretation and execution of appropriate social cues are some of the most common observable
symptoms of autism. Any potential deficiencies of DA transmission due to Purkinje cell
dysfunction from the dentate, as seen in individuals with autism, make the striatum and NAc
viable nuclei to explore in the proposed study. The current studied pathways are depicted in
Figure 1.

37

Figure 1. Representative diagram of explored pathways in current studies and of DN: dentate
influence on Striatum and NAc: nucleus accumbens dopamine release. RTN: reticulotegmental
nucleus, PPT: pedunculopontine tegmentum, VTA: ventral tegmental nucleus, SN: substantia
nigra, PFC: prefrontal cortex. Excitatory (glutamatergic) – red lines; dopaminergic – green lines.
Stimulation site – gray, recording site – yellow.
Previous studies have shown aberrant striatal functionality and connectivity within the
anterior cingulate and frontal cortex, orbitofrontal cortex, and the brain stem (Di Martino et al.,
2011). This could be closely linked to the evidence of attenuation and reorganization of
cerebellar modulation in DA release in the PFC of Lurcher mutant and Fmr1 mice (rodent
models that exhibit dysfunction or absence of Purkinje cellular influence in the cerebellum),
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along the ventral tegmental area (VTA) and thalamic pathways, which originate in the dentate
(Mittleman et al. 2008; Rogers et al., 2011, 2013a).
Selection of Rodent Models of ASDs
There are currently five commonly used genetic rodent models with neural and
behavioral abnormalities coinciding with those seen in autism (Rogers et al., 2013b). However,
the Fmr1 knockout mouse seems to be the most relevant to the current study. Fragile-X
syndrome is the most common monogenetic cause of autism, stemming from the silencing of the
FMRP gene (El Idrissi et al., 2005). Fmr1 wildtype mice will be used in all assays of the
experiment. Fmr1 wildtype are a normal control mouse, and provide for a good experimental
control in conjunction with their mutant strain counterpart. Fmr1 KO (mutant) display cerebellar
abnormalities such as elongated Purkinje cell spines and decreased volume of cerebellar nuclei
(Koekkoek et al., 2005; Ellegood et al., 2010). This will allow an appropriate comparison
between current wildtype Fmr1 and Fmr1 KO. Fmr1 KO have an Fmr1tm1Cgr targeted mutation
and are widely used as a mouse model of Fragile X syndrome (Verkerk et al. 1991; GoodrichHunsaker et al. 2011). The Fmr1 mouse strain also allows for potential generalizations to other
strains that have similar cerebellar abnormalities pertaining to cerebellar Purkinje cells, such as
the Lurcher mouse strain. Both the Fmr1 and Lurcher mutants show deficits in cognitive
functioning (Dickson et al., 2013), as well as nearly identical neurochemical deficits along the
DN-PFC pathways (Rogers et al., 2013).
Method
Animals
Experimental subjects were bred and maintained in the Animal Care Facility located in
the Department of Psychology at the University of Memphis. Mice were continuously
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maintained in a temperature-controlled environment (21±1 °C) on 12:12 light/dark cycle (lights
on at 0800) and given food and water ad libitum. All experiments were approved by the local
Institutional Animal Care and Use Committee and conducted in accordance with the National
Institutes of Health Guidelines for the Care and Use of Laboratory Animals (2011).
Breeding
Two phases of breeding were required to produce Fragile X mice (Fmr1) for the present
study. The first stage consisted of male mice hemizygous for the Fmr1tm1Cgr targeted mutation
(FVB. 129P2-Fmr1tm1Cgr/J, #004624) being mated with female wildtype control mice
(FVB.129P2-Pde6b+ Tyrc-ch/AntJ, #004828). The initial offspring produced litters were
composed of heterozygous females and wildtype males. The second stage consisted of
heterozygous female mice being mated with wildtype male mice to produce litters containing
both hemizygous and wildtype males. Only the wildtype littermates were used as experimental
subjects in the current study.
Surgery
A total of 51 adult Fmr1 mice were used; 13 (8 WT, 5 KO) for assays in the NAcc, 12
(8,4) for assays in the NAcsh, 9 (6,3) for assays in the DMS, and 17 (7,10) for assays in the
dorsolateral striatum (DLS). All were urethane-anesthetized (1.5 g/kg i.p.) and placed in a
stereotaxic frame. Body temperature was maintained at 36±0.5 °C with a temperature-regulated
heating pad. Fixed potential amperometry (FPA) was used with a concentric bipolar stimulating
electrode (SNE-100, Kopf Instruments), a carbon-fiber microelectrode (DA recording electrode;
carbon fiber 10 µm o.d., 250 µm length, Thornel Type P, Union Carbide, Bristol, PA, USA), and
an Ag/AgCl reference/auxiliary (stainless steel 30g wire) electrode combination. In individual
mice, the stimulating electrode was implanted to a site contralateral to the recording electrode
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implanted in the left hemisphere, while the reference/auxiliary electrode was implanted
ipsilateral and anterior to the stimulating electrode onto the surface of the cortex. Stimulating and
recording electrodes were implanted based on coordinates with respect to bregma and depth with
respect to dura. The stimulating electrode was implanted in the DN of the cerebellum, (in
millimeters, AP -6.25, ML +2.1, and DV -2.4), and the recording electrode in either the NAcc
(AP +1.5, ML +0.8, and DV -3.8), NAcsh (AP +1.5, ML +0.8, and DV -3.8), DMS (AP +1.5,
ML +0.8, and DV -3.8) or the DLS (AP +1.5, ML +0.8, and DV -2.8). Figure 2 indicates
stimulation and recording sites. All coordinates were selected based on stereotaxic coordinates
from the mouse brain atlas (Paxinos & Franklin, 2001).

Figure 2. Experimental design to evaluate effects of DN electrical stimulation-evoked NAcc,
NAcsh, (nucleus accumbens) DMS, and DLS (striatum) dopamine release. RTN:
reticulotegmental nucleus, PPT: pedunculopontine tegmentum, VTA: ventral tegmental nucleus,
SN: substantia nigra, mPFC: prefrontal cortex. Inhibitory (GABAergic) – blue line; excitatory
(glutamatergic) – red lines; dopaminergic – green lines.
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Fixed-Potential Amperometry and Electrical Stimulation
FPA coupled with carbon-fiber DA recording microelectrodes has been shown to be a
valid technique for real-time monitoring of stimulation-evoked DA release (Forster & Blaha,
2003; Agnesi et al., 2009; Agnesi, Blaha, Lin & Lee, 2010). Following implantation of all
electrodes a fixed positive potential (+0.8 V) was applied to the recording electrode and
oxidation current, reflective of DA concentrations, measured continuously via the recording
electrode (10 K samples/s) via an electrometer (ED401 e-corder 401 and EA162 Picostat, eDAQ
Inc., Colorado Springs, CO, USA) filtered at 10 Hz low pass. A total of 15 stimulations (50
monophasic 0.5 ms duration pulses at 50 Hz every 60 s) were applied to the DN (at 800 µAmps)
via the stimulating electrode with use of an optical isolator and programmable pulse generator
(Iso-Flex/Master-8; AMPI, Jerusalem, Israel).
Data Analysis
DN stimulation-evoked responses during each assay were reduced from 10,000 samples
per second to 100 samples per second and extracted from the continuous record and
amperometric currents within a range of 0.2 s prestimulation and 45 s poststimulation. Raw
values at intervals of 0.05 s (-0.2 s through 45 s) of evoked response currents (pico amps) were
used as a dependent measure. The values at -0.2 s was zeroed to establish a baseline and all
following values were adjusted to a uniform measure to allow unbiased comparison of peak
oxidation current. All data points were exponentially smoothed, with a damping factor of 0.7, to
eliminate any static noise that was present due to the recording technique. Stimulation artifacts
were dismissed in the evaluation of the stimulation evoked DA release measure. Initial one-way
analysis of variance (ANOVA) evaluated the four recording sites independently for any
significant differences in evoked response between the Fmr1 wildtype and KO strains. All
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ANOVA’s were evaluated such that an alpha level of p < 0.05 was considered statistically
significant.
Results
As shown in Figure 3, stimulation-evoked DA release was determined to be present in the
NAcc, NAcsh, DMS and DLS in the Fmr1 wildtype and KO mouse. DN stimulation induced an
average increase in DA oxidation current 9.52 ± 1.46 and 7.25 ± 0.6 in the NAcc, 3.8 ± 0.4 and
3.2 ± 0.5 in the NAcsh, 7.18 ± 0.65 and 8.1 ± 0.76 in the DMS, and 8.5 ± 1.3 and 6.8 ± 0.8 in the
DLS, in Fmr1 wildtype and KO mice respectively. Mean ± SEM DA oxidation current values
are shown in Figure 4.

Figure 3. Representative NAc and striatum DA release profile following DN stimulation in the
Fmr1 wildtype mouse.
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Figure 4. Mean ± S.E.M. cerebellar dentate nucleus (DN) stimulation-evoked increase in
dopamine oxidation current (picoamps) corresponding to dopamine release in the nucleus
accumbens core (NAcc), nucleus accumbens shell (NAcsh), dorsomedial striatum (DMS), and
dorsolateral striatum (DLS) in Fmr1 wildtype and Fmr1 KO mice. No significant differences
seen.
One-way ANOVAs were performed at each of the four recording sites NAcc, NAcsh,
DMS, and DLS. The ANOVAs evaluated any possible significant differences in relative
stimulation evoked mPFC DA release between the Fmr1 wildtype and KO strains. The ANOVAs
showed no significant main effect in differences of DA release in any of the recording locations:
NAcc [F (1,12) = 4.13, p = 0.065], NAcsh [F (1,11) = 1.27, p = 0.28], DMS [F (1,8) = 2.68, p =
0.14], and DLS [F (1,16) = 3.73, p = 0.071].
Histology
Immediately following each experiment, a direct current (100 µA for 10s; +5 V for 5 s)
was passed through the stimulating electrode in the DN and through the recording electrode in
either the mPFC, NAcc or DMS to lesion tissue, respectively. Each mouse was euthanized with a
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lethal intracardial injection of urethane. Brains were removed and preserved overnight in 10%
buffered formalin containing 0.1 % potassium ferricyanide, and then stored in 30 % sucrose/10
% formalin solution until sectioning. At the conclusion of the experiment brains were sectioned
on a cryostat at -30 ̊C. A Prussian blue spot indicative of the redox reaction of ferricyanide and
iron deposits labeled the stimulating electrode in the DN, and the electrolytic lesion determined
the location of the recording probe. All placements were noted on representative coronal
diagrams (Paxinos & Franklin, 2001).
Histological analysis provided averages for each recording site, from bregma or dura, in
the NAcc in mm ( n = 8, 5; AP +1.5 mm ± 0.26 ML +0.8 mm ± 0.26 and DV -3.8 mm ± 0.63),
the NAcsh (n=8, 4; AP +1.5 mm ± 0.15, ML +0.4 mm ± 0.19 and DV -4.0 mm ± 0.52), the DMS
(n=6, 3; AP +1.5 mm ± 0.15, ML +0.8 mm ± 0.31 and DV -2.8 mm ± 0.37) and the DLS (n=7,
10; AP +1.5 mm ± 0.15, ML +1.7 mm ± 0.37 and DV -3.0 mm ± 0.71) Fmr1 wildtype and KO
respectively. The stimulation site in the DN showed averages, from bregma, of (AP -6.25mm ±
0.2, ML -2.1mm ± 0.30 and DV -2.4mm ± 0.42) for all groups. Both stimulation and recording
sites are shown in Figure 5.
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Figure 5. Histology: average locations of a Prussian blue spot indicative of ferricyanide redox
reaction produced iron deposits labeling the stimulation electrode in the DN, and the location of
the recording electrodes in the nucleus accumbens core (NAcc) nucleus accumbens shell
(NAcsh), dorsomedial striatum (DMS) and dorsolateral striatum (DLS) by electrolytic lesion.
Discussion
Evidence of functional pathways from the DN to the NAcc, NAcsh, DMS, and DLS were
clearly shown via DN stimulation-evoked DA release in the Fmr1 wildtype and KO mice.
However, interestingly there was no significant difference in modulation of DA in either the
nucleus accumbens or the striatum found between Fmr1 wildtype and KO mice. The presence of
DA release complement much of the previous findings of DN to mPFC pathways in the
modulation of DA release (Rogers et al., 2011, 2013a). However, results were contrary to
previous research with respect to an expected attenuation, hypothesized as a decrease in DA in
the KO mouse, due to the elongation of, and therefore dysfunction of Purkinje cells in the
cerebellum. This does not dismiss the disconnection hypothesis as relevant to ASDs, but instead
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encourages further exploration as potential compensatory mechanisms could be present within
the mesocortical and nigrostriatal dopaminergic systems, producing significant differences in the
mutant versus control strain.
The current study explored solely DA release, and did not address neurotransmitter
binding efficacy or receptor activation. The D1 and D2 G-protein coupled receptors (D1DR,
D2DR) within the striatum are dependent on spatiotemporal signaling that play major roles in the
inhibition network which has been shown to be deficient in neurodegenerative diseases such as
schizophrenia, addictive disorders, and Parkinson’s disease (Gauggel, Rieger, & Feghoff, 2003;
Barnett et al., 2010; Koob & Volkow, 2010). When the described inhibition network (anterior
cingulate gyrus, middle cingulate gyrus, and insula) is evaluated in high-functioning individuals
with autism, these brain regions (right middle and inferior frontal and parietal regions) show
decreased activation and connectivity (Kana, Keller, Minshew, & Just, 2007). Di Martino and
colleagues (2011) have shown the striatum has the ability to branch to regions in the brain
described above influenced by the inhibition network that ultimately form connections not
commonly seen in a healthy developing child. This new hypothesis that a potential modulation of
connectivity to brain regions associated with D1DR and D2DR receptors in the inhibition
network could be shown behaviorally in Fmr1 KO mice allowing for a better understanding of a
modulation along the mesocortical and nigrostriatal pathways as relevant to ASDs.
In the Fmr1 KO mice the current research presents a null finding in the striatum and
nucleus accumbens following stimulation in the DN, as compared to the Fmr1 wildtype control.
The lack of any evidence to support the hypothesized decrease in DA release in the Fmr1 KO
mouse implicates the need to further explore other nuclei within both the mesocortical and
nigrostriatal pathways in search of any potential compensatory mechanisms or aberrations due to
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DN modulation within the Fmr1 mouse. The current results also implicate the need to explore the
same research paradigm within the Lurcher mutant mice, model with complete Purkinje cell loss,
and compare to their wildtype control strain. It is hypothesized there would be a significant
decrease in DA release in the Lurcher mutant strain; suggesting that absence of Purkinje cells
and not solely dysfunction, as in the Fmr1 KO, would elicit differences in striatal and accumbens
DA release following DN stimulation.
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Chapter 4
Cerebellar Neuropathology Influences Compensatory Mechanisms in the Lurcher Mouse
in Pre Frontal Cortex Dopamine Release
Introduction
Autism is a spectrum of neuropsychiatric disorders which occurs in young children
generally before the age of six. Autism ranges in severity but is typically characterized by
deficits in social skills and communication, unusual and repetitive behavior, and deficits in
executive function. Autism is one of the most common developmental disorders affecting
approximately 1 out of every 68 children (CDC, 2014). The degree of cognitive and executive
function deficiencies vastly differs from individual to individual, however cerebellar hypoplasia
and reduced Purkinje cell numbers are the most reproducible neural pathologies linked with
autism (Courchesne, et al., 1988; Bauman, 1991; Courchesne 1997). The cerebellum, while
traditionally thought to be strictly involved in motor function, posture, and balance, is now
generally accepted to be involved in cognitive functions such as associative learning, verbal
ability, planning, and working memory (Bracke-Tolkmitt, 1991; Schmahmann, 1991; Rapport,
Van Reekum, & Mayberg, 2000; Kumar et al., 2010). Individuals with autism also have
abnormalities associated with the cerebellum
Previously, it has been shown that prefrontal cortex dopamine (PFC DA) release evoked
by electrical stimulation of the cerebellar dentate nucleus (DN) is attenuated in Lurcher mutant
mice lacking Purkinje cells (Mittleman, Goldowitz, Heck & Blaha, 2008). We have also shown
that neuronal circuits for this modulation involve glutamate (Glu) DN projections to
reticulotegmental nuclei (RTN), then to pedunculopontine tegmental nuclei (PPT), and finally to
ventral tegmental area (VTA) mesocortical DA neurons (Schwarz & Schmitz, 1997; Garcia-Rill,
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Skinner, Miyazato, & Homma, 2001; Rogers et al., 2011). A second dual circuit involves Glu
DN inputs to mediodorsal (ThN md) and ventrolateral (ThN vl) thalamic nuclei that in turn send
Glu inputs to the PFC to make appositional synapses with VTA DA inputs onto PFC pyramidal
cells (Middleton & Strick, 2001; Forster & Blaha, 2003). We have also shown that there is a
decrease in the amount of localized Glu release in these two circuits (McKimm et al., 2014).
Our findings above in Lurcher (Lc) mutant mice suggest possible differences in the
strength of dopaminergic VTA and/or thalamic nuclei to PFC as a result of aberrations in the
cerebellar cortical projections from the DN in Lc mutant mice. Whether these alterations in
dopaminergic strength occur selectively in thalamic inputs to the PFC, VTA inputs to the PFC,
or both of these pathways is addressed in this study. These previous findings are in agreement
with the Autism Disconnection Hypothesis which states that autism results, at least in part, from
an interruption of circuitry between the cerebellum and PFC. Thus, impaired connectivity
between the cerebellum and PFC could account for certain cognitive symptoms of autism.
The aim of the present study was to evaluate any adaptations, modulations, and
ultimately any potential evidence of compensatory mechanisms in midbrain nuclei that may alter
the effects of cerebellar hypoplasia with regards to PFC DA release. Previous studies have
clearly shown the direct effects of elongation of, or absence of Purkinje cells within the DN by
stimulation of the DN and recording DA in the mPFC (Rogers et al., 2013a; 2013b). The
systemic influence of each nuclei along the DN-VTA-PFC and DN-Thalamic-PFC pathways is
documented in the aforementioned studies, however each individual nuclei’s influence on mPFC
DA release has not been as addressed as it will be in the current study. Previous studies
individually ‘silenced,’ by means of localized anesthetic, specific nuclei and evaluated the direct
effects on mPFC DA release. The current study expands on this ‘silencing’ by eliminating the
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potential confounds of possible compensatory mechanisms within the two explored pathways
during localized anesthesia, by means of electrical stimulation of the VTA, ThN md, and ThN vl
while recording changes in oxidation current corresponding to DA release in the mPFC. In
summary, the current study is to determine the differences in relative dopamine release in the
PFC following ThN md, ThN vl, and VTA stimulation in Lc mutant and Lc wildtype mice to
evaluate possible differences in the relative strength of glutamatergic and dopaminergic
pathways downstream from the DN, mediating PFC DA release related to cerebellar Purkinje
cell density.
Method
Animals
Experimental subjects were bred and maintained in the Animal Care Facility located in
the Department of Psychology at the University of Memphis. Mice were continuously
maintained in a temperature-controlled environment (21±1 °C) on 12:12 light/dark cycle (lights
on at 0800) and given food and water ad libitum. All experiments were approved by the local
Institutional Animal Care and Use Committee and conducted in accordance with the National
Institutes of Health Guidelines for the Care and Use of Laboratory Animals. Original Lurcher
(#001046) and Fmr1 breeders (#004624, #004828) were purchased from The Jackson Laboratory
(Bar Harbor, Maine).
Breeding
To produce lurcher mutant mice, ataxic male mice heterozygous for the lurcher
spontaneous mutation (B6CBACa Aw-J/A-Grid2Lc) were bred with non-ataxic female wildtype
mice (B6CBACa Aw-J/A-Grid2+). This breeding strategy produced litters composed of both
heterozygous mutant and wildtype mice. Two phases of breeding were also required to produce
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Fmr1 mutant mice. In the first phase, male mice hemizygous for the Fmr1tm1Cgr targeted mutation
(FVB.129P2-Fmr1tm1Cgr/J) were bred with female wildtype mice (FVB.129P2-Pde6b+ Tyrcch

/AntJ). This breeding strategy produced litters composed only of heterozygous females and

wildtype males. In the second phase, heterozygous female mice were bred with wildtype male
mice to produce litters containing both hemizygous and wildtype males which were subsequently
used as experimental subjects. Due to their ataxic gait, mice heterozygous for the Lurcher
mutation are easily distinguishable from their non-ataxic wildtype littermates.
Surgery
A total of 11 adult male Lc wildtype mice and a total of 9 adult male Lc KO mice were
used. Respectively, 4 and 3 were used for assays in the VTA, 4 and 3 for assays in the ThN vl,
and 3 and 3 for assays in the ThN md. All were urethane-anesthetized (1.5 g/kg i.p.) and placed
in a stereotaxic frame. Body temperature was maintained at 36±0.5 °C with a temperatureregulated heating pad. Fixed potential amperometry (FPA) was used with a concentric bipolar
stimulating electrode (SNE-100, Kopf Instruments), a carbon-fiber microelectrode (DA
recording electrode; carbon fiber 10 µm o.d., 250 µm length, Thornel Type P, Union Carbide,
Bristol, PA, USA), and an Ag/AgCl reference/auxiliary (stainless steel 30g wire) electrode
combination. In individual mice, the stimulating electrode was implanted to site ipsilateral to the
recording electrode implanted in the left hemisphere, while the reference/auxiliary electrode was
implanted ipsilateral and anterior to the stimulating electrode onto the surface of the cortex. The
recording electrode was inserted at a 30° lateral to medial angle. Stimulating and recording
electrodes were implanted based on coordinates with respect to bregma and depth with respect to
dura. The stimulating electrode was implanted in the VTA, (in millimeters, AP -3.3, ML +0.35,
and DV -4.0), the ThN vl (AP +1.35, ML +1.0, and DV -3.45), the ThN md (AP +1.35, ML

61

+0.4, and DV -2.75), and the recording electrode in the mPFC (AP +2.35, ML +1.0, and DV 1.5). Figure 1 depicts experiment design of stimulation and recording sites. All coordinates were
selected based on stereotaxic coordinates from the mouse brain atlas (Paxinos & Franklin, 2001).

Figure 1. Schematic diagram of the mouse brain illustrating a typical setup for in vivo fixed
potential amperometric recording of stimulation-evoked medial prefrontal cortex (mPFC)
dopamine release. A carbon-fiber recording electrode was positioned in either the medial
prefrontal cortex (mPFC). A stimulating electrode was positioned in the ventral tegmental area
(VTA), the mediodorsal thalamic nuclei (md ThN), or the ventrolateral thalamic nuclei (vl ThN).
A silver/silver chloride reference and stainless-steel auxiliary electrode combination was placed
in contact with contralateral cortical tissue. Inhibitory (GABAergic) – blue line; excitatory
(glutamatergic) – red lines; dopaminergic – green lines.
Fixed-Potential Amperometry and Electrical Stimulation
FPA coupled with carbon-fiber DA recording microelectrodes has been shown to be a
valid technique for real-time monitoring of stimulation-evoked DA release (Forster & Blaha,
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2003; Agnesi, Blaha, Lin & Lee, 2010; Agnesi et al., 2009). Following implantation of all
electrodes a fixed positive potential (+0.8 V) was applied to the recording electrode and
oxidation current, reflective of DA concentrations, measured continuously via the recording
electrode (10 K samples/s) via an electrometer (ED401 e-corder 401 and EA162 Picostat, eDAQ
Inc., Colorado Springs, CO, USA) filtered at 10 Hz low pass. A total of 15 stimulations (50
monophasic 0.5 ms duration pulses at 50 Hz every 60 s) were applied to the DN (at 800 µAmps)
via the stimulating electrode with use of an optical isolator and programmable pulse generator
(Iso-Flex/Master-8; AMPI, Jerusalem, Israel).
Data Analysis
DN stimulation-evoked responses during each assay were extracted from the continuous
record and amperometric currents within a range of 0.2 s prestimulation and 45 s poststimulation.
Raw values at intervals of 0.05 s (-0.2 s through 45 s) of evoked response currents (pico amps)
were used as a dependent measure. Stimulation artifacts were dismissed in the evaluation of the
stimulation evoked DA release measure. Initial one-way analysis of variance (ANOVA)
evaluated the three stimulating sites independently for any significant differences in evoked
response between the Lc mutant and wildtype control counterpart. All ANOVA’s were evaluated
such that an alpha level of p < 0.05 was considered statistically significant.
Results
As shown in Figure 2, stimulation-evoked DA release was determined to be present in the
mPFC following stimulation in the VTA, ThN vl, and ThN md, in both the Lc wildtype and
mutant strains. VTA stimulation-evoked increases in DA oxidation current (in nanoamps) in the
PFC was 0.027 ± 0.011 and 0.087 ± 0.029 for Lc wildtype and Lc mutant mice, respectively.
ThN vl stimulation increased DA oxidation current in the PFC by 0.048 ± 0.026 and 0.051 ±
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0.023 in Lc wildtype and Lc mutant mice, respectively. Finally, ThN md stimulation increased
DA oxidation current in the PFC by 0.088 ± 0.023 and 0.043 ± 0.020 in Lc wildtype and Lc
mutant mice, respectively. Average DA oxidation currents for all three stimulated nuclei are
shown in figure 3. With respect to wildtype versus mutant mice, an ANOVA revealed a
significant main effect for VTA stimulation-evoked DA release [F (1, 5) = 15.57, p = 0.01] in the
direction of Lc mutant mice exhibiting greater increases in DA oxidation current. An ANOVA
revealed no significant main effect for ThN vl stimulation-evoked DA release [F (1, 5) = 0.031,
p = 0.87]. An ANOVA revealed a significant main effect for ThN md stimulation-evoked PFC
DA release in the direction of Lc wildtype mice exhibiting greater increases in DA oxidation
current, [F (1, 4) = 6.85, p = 0.05]. The VTA exhibited a relative +31% shift in DA release away
from the Lc wildtype mouse towards the Lc mutant mouse, the ThN vl showed no significant
differences, and the ThN md exhibited a relative -49% shift in DA release towards the Lc
wildtype mouse, pathways and relative percentages depicted in figure 4.
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Figure 2. Representative PFC DA release profile following ThN md stimulation in the Lc
wildtype and Lc mutant mice.

Figure 3. Mean ± S.E.M. ventral tegmental area (VTA), ventrolateral thalamic nuclei (ThN vl)
and mediodorsal thalamic nuclei (ThN md) stimulation-evoked increase in dopamine oxidation
current (nanoamps) corresponding to dopamine release in the medial prefrontal cortex (mPFC).
* Significant differences in stimulation-evoked DA release.
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Figure 4. Ventral tegmental area (VTA), ventrolateral thalamic nuclei, (ThN vl), and
mediodorsal thalamic nuclei (ThN md) stimulation-evoked dopamine release in Lc mutant and
Lc wildtype mice. Relative differences shown in stimulation-evoked dopamine release in the
VTA and ThN md. No significant difference observed in the ThN vl.
Histology
Immediately following each experiment, a direct current (100 µA for 10s; +5 V for 5 s)
was passed through the stimulating electrode in the VTA, ThN vl, or ThN md, and through the
recording electrode in the mPFC lesion tissue. Each mouse was euthanized with a lethal
intracardial injection of urethane. Brains were removed and preserved overnight in 10% buffered
formalin containing 0.1% potassium ferricyanide, and then stored in 30% sucrose/10% formalin
solution until sectioning. At the conclusion of the experiment brains were sectioned on a cryostat
at -30 C
̊ . A Prussian blue spot indicative of the redox reaction of ferricyanide and iron deposits
labeled the stimulating electrode in the DN, and the electrolytic lesion determined the location of
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the recording probe. All placements were noted on representative coronal diagrams (Paxinos &
Franklin, 2001).
Histological analysis provided averages for each recording site, from bregma, for Lc
wildtype and Lc mutant, respectively, in the VTA, (in millimeters, n = 4: AP -3.3 ± 0.3, ML
+0.35 ± 0.5, and DV -4.0 ± 1.1; n=3: AP -3.3 ± 0.4, ML +0.35 ± 0.6, and DV -4.0 ± 1.2), the
ThN vl (n=4: AP +1.35 ± 0.2, ML +1.0 ± 0.7, and DV -3.45 ± 0.9 ;n=3: AP +1.35 ± 0.4, ML
+1.0 ± 0.6, and DV -3.45 ± 1.1), the ThN md (n=3: AP +1.35 ± 0.5, ML +0.4 ± 0.2, and DV 2.75 ± 0.8; n=3: AP +1.35 ± 0.8, ML +0.4 ± 0.6, and DV -2.75 ± 0.5), and the recording
electrode in the mPFC (AP +2.35 ± 0.6, ML +1.0 ± 0.9, and DV -1.5 ± 1.0). Both stimulation
and recording sites are shown in Figure 5.
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Figure 5. Histology: average locations of a Prussian blue spot indicative of ferricyanide redox
reaction produced iron deposits labeling the stimulation electrode in the ventral tegmental area
(VTA), ventrolateral thalamic nuclei (ThN vl), or mediodorsal thalamic nuclei (ThN md), and
the recording electrodes in the medial prefrontal cortex (mPFC) by electrolytic lesion.
Discussion
Congruent with previous findings stimulation-evoked PFC DA release was observed in
both the Lc wildtype and mutant mice. Rogers and colleagues, as well as McKimm and
colleagues showed that there is roughly a 50:50 split between the VTA and dorsomedial and
ventrolateral thalamic nuclei originating in the DN projecting to the PFC (2013a, 2014). The
present research examined the impact of developmental loss of cerebellar Purkinje cells (Lurcher
mutant mice) on VTA dopaminergic and thalamic glutamatergic pathways mediating PFC DA
release in the cerebellar/DN to PFC neuronal systems. Rogers and colleagues show there is a
modulatory shift in strength towards the ThN vl and away from the VTA and ThN md (2013a).
The results here present that the shift towards the ThN vl have balanced the glutamatergic
projections from the DN to the ThN vl, as no significant differences were seen between the Lc
wildtype and mutant strains. There does appear however to be compensatory mechanisms
occurring in both the ThN md and the VTA, interestingly in opposite directions. Stimulation in
the VTA displayed increases in DA oxidation current in the mPFC of the Lc mutant compared to
the Lc wildtype, while stimulation in the ThN md displayed increases in DA oxidation current in
the Lc wildtype compared to the Lc mutant.
The shift in strength, when exposed to lidocaine and kynurenate, within the thalamic
nuclei towards the ventrolateral aspect may provide some stability in the nuclei and leave
potential variability and vulnerability of DN influence. The absence or dysfunction of Purkinje
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cerebellar cells that project to the DN have been shown to result in an attenuation in DN
stimulation-evoked PFC DA release (Rogers et al., 2013a; McKimm et al., 2014). The present
result of greater increases in ThN md stimulation-evoked DA oxidation current in the Lc
wildtype animal as compared to the Lc mutant supports this hypothesis. Shifts in strength
towards the ThN vl, and similar levels of stimulation-evoked DA release in the mPFC seen in the
Lc wildtype and mutant strains in the ThN vl, suggest a greater influence of DN to mPFC DA
release, however one that is consistent between the Lc wildtype and mutant strains. This
potentially stresses importance on influencing aberrations in the pathway at the level of ThN md
nuclei.
The VTA surprisingly paints a slightly different picture. As seen by McKimm and
colleagues (2014) there was an overwhelmingly significant difference between the Lc wildtype
and mutant mouse in glutamate release in the RTN, while no significant differences in the VTA
or the PPT. Initially it was hypothesized in the event of Purkinje cell absence or dysfunction
there would be a systemic decrease in both glutamatergic and dopaminergic influence in the
PFC. However, what the current results show instead is that following an overwhelmingly
significant difference in glutamate release in the RTN, the Lc mutant brain is exhibiting
compensatory mechanisms in the VTA. Such compensatory mechanisms could be present to
attempt to counter the neurochemical imbalance observed upstream at the RTN, or the VTA
could be the site of a feedback system following decreased mPFC DA release in the Lc mutant
animal.
Between groups comparison revealed statistically significant differences when comparing
Lc wildtype and mutant mice in the VTA and the ThN md, with p-values of 0.01 and 0.05,
respectively. While no significant difference was revealed in the ThN vl with a p-value of 0.87.
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What is more interesting is the difference in modulatory effects with an increase in mPFC DA in
the Lc wildtype mouse in the ThN md, and an increase in the Lc mutant mouse in the VTA.
Further exploration of the Purkinje cells functional and dysfunctional influence on the DN-RTNPPT-VTA-mPFC and DN-ThN-mPFC neuronal circuitry is warranted. Clinical imaging and
lesion studies support the hypothesis that the cerebellum and reciprocal connections to the mPFC
may influence executive functions (Bracke-Tolkmitt et al., 1989; Schmahmann and Sherman,
1998). Delmonte and colleagues (2013) have also shown increased functional connectivity in
frontostriatal circuitry is associated with behavioral characteristics of ASD, with hyper
connectivity confined to the limbic and associative frontostriatal circuits. This implicates a
developmental disruption in pathway organization, likely due to cerebellar pathology, ultimately
allowing for potential vulnerabilities and modulation along the cerebellar-DN-mPFC pathways.
Many of the executive function and behavioral symptomatology that individuals with autism
present are mimicked in experimental studies that relate to a disconnection of the cerebellar-DNPFC circuitry.
Conclusion
The present findings support previous findings of cerebellar Purkinje cell influence on
mPFC dopamine release. There was an attenuation seen in the mediodorsal region of the
thalamus coinciding with the notion that an absence or dysfunction of Purkinje cells decreases
the levels of mPFC DA, ultimately leading to various cognitive and behavioral deficits,
commonly seen in individuals with autism and other psychiatric disorders. Secondly, there
appears to be compensatory mechanisms present in the VTA to modulate deficiencies in
glutamatergic influence along the DN-RTN-PPT-VTA pathway. A modulation resulting in an
increase in dopaminergic activity in the mPFC in the Lc mutant strain lacking Purkinje cells.
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Both the aberrations and compensatory mechanisms observed in the present study lend additional
support to the disconnection hypothesis; that the etiology of any given disorder can be attributed
to a loss of connectivity between brain structures (Catani & Ffytch, 2008).
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Chapter 5
Summary, Conclusions, and Future Directions
ASDs incidence and prevalence rates are growing at alarming rates with reported
increases in new diagnoses of 6-15% each year from 2002 to 2012 (CDC, 2016). The etiology of
ASDs are still relatively unknown, our current and previous research emphasizes a heavy
influence on neurodevelopmental aberrations within the cerebellum. Traditionally, the
cerebellum has been known to be responsible for movement coordination, however recent
studies show evidence of the cerebellum’s influence on cognition, specifically emotion
regulation and social cognition, including mental flexibilities, spatial organization, linguistic
processing, mood and others; cognitions that are influential on disorders including ASDs, mood
disorders, attention deficit and other psychiatric disorders (Shakiba, 2014; Fatemi, & Folsom,
2014; Wang, Kloth, & Badura, 2014). Despite varying predispositions to the development of
ASDs, cerebellar neuropathology consisting of cerebellar hypoplasia and reduced Purkinje cell
numbers appears to be one of the largest neurological commonalities with regards to autism (
Courchesne, Yeung-Courchesne, Press, Hesselink, & Jemigan, 1988; Bauman, 1991; Courchesne
et al., 1994; Courchesne, 1997; Palmen, Van Engeland, Hof & Schmitz, 2004; DiCicco et al.,
2006; Whitney, Kemper, Bauman, Rosene, & Blatt, 2008). Our previous and current studies
show aberrations within the cerebello-cortical circuitry with regards to both glutamatergic and
dopaminergic projections, ultimately influencing PFC DA release. The element of cerebellar
influence on both the nucleus accumbens and striatum have also been introduced in the present
studies. Functional clinical trials of brain studies with individuals with ASDs are primarily
behavioral and imagining in basis, much of the neurological genesis of the disorder is still very
rudimentary. Due to the limited ability of clinical and therapeutic techniques in humans, rodent
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models provide a good medium to further advance and support clinical findings, by means of
opening the black box that is the brain and explore the neuronal pathways.
The experiment in Chapter 3 introduces the notion of cerebellar influence on higher order
cognitions, executive functioning and emotion regulation along the DN → RTN → PPT → VTA
→ NAc/ST nuclei within the nigrostriatal, mesolimbic and mesocortical pathways. The striatum
within the nigrostriatal pathway was explored due to its functionality associated with reward and
inhibition processing, as well as motor programs that are conducive in reward-seeking behavior
and executive functioning and goal-direct behavior (Graybiel, Aosaki, Flaherty, & Kimura,
1994; Da Cunha, Gomex, & Blaha, 2012; Kravitz & Kreitzer, 2012). The nucleus accumbens
within the mesolimbic pathway was explored due to its functionality with reward processing as
well as social activation and inhibition, and has been closely linked to non-motor, cognitive and
reward functioning (Schultz, 2016). All executive functions that are disconnected or deficient in
individuals with autism.
The present findings show cerebellar influence of the DN to all of the following studied
areas, NAcc, NAcsh, DMS, and DLS, despite any significant differences in relative stimulationevoked DA release in any of the studied areas. The brain is very plastic, especially when
vulnerable to something like ASDs and other neurodegenerative diseases. The evidence of D1
and D2 G-protein coupled receptors are dependent on spatiotemporal signaling that is often
deficient in neurodegenerative diseases (Gauggel, Rieger, & Feghoff, 2003; Barnett et al., 2010;
Koob & Volkow, 2010). Additionally, these brain areas show decreased activation and
underconnectivity in individuals with high-functioning autism (Kana, Keller, Minshew, & Just,
2007). It was hypothesized that there would be distinct differences seen between the Fmr1
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wildtype and KO, however this was not present in the current study, likely due to complexities
and resilience of the brain nuclei discussed above.
Moving forward it would be important to explore the studied pathways in the Lurcher
strain to see if absence rather than elongation of cerebellar Purkinje cells has an influence on
these basal ganglia nuclei. It would also be beneficial to couple both the Fmr1 and Lurcher
strains in a behavioral delayed reward task with D1/D2 receptor antagonists with regards to
behavioral inhibition similar to the ones performed by Eagle and colleagues (2011). This would
lend support to the hypothesis of compensatory mechanisms occurring to restore normal levels of
striatal and nucleus accumbens DA release, despite still exhibiting behavior inhibition and other
executive functioning deficiencies.
The experiment in Chapter 4 further expands on previous research on the mesocortical
pathways explored by Rogers and colleagues as well as McKimm and colleagues (2011, 2013a;
2014). Rogers and colleagues have shown there is roughly a 50:50 split between the DN → RTN
→ PPT → VTA → PFC and DN → ThN → PFC pathways, with a modulatory shift towards the
ThN vl away from the ThN md (2011, 2013a). McKimm and colleagues have shown similar
50:50 splits, however primary exhibiting glutamatergic modulatory effects in the ThN md, ThN
vl, and RTN, with no such modulatory effects in glutamate in the PPT or VTA. The study in
Chapter 4 shows evidence that there is some form of a compensatory shift in the wildtype animal
in immediate DA release in the mPFC following stimulation in the ThN md, and VTA. What is
interesting is the modulation in the ThN md occurred in the wildtype animal, whereas a
compensatory change in the mutant strain occurred in the VTA. This is likely an example of the
brain’s resiliency to aberrations and dysfunction within neurodegenerative diseases.
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Future directions should be focused on the importance of exploring DA release in the
mPFC following PPT and RTN direct stimulation, and it is hypothesized, based on the current
findings, that there would be higher levels of DA release in the wildtype animal in the RTN,
however the PPT will likely show the start of compensatory efforts within the mutant animal.
The current study performed in the Fmr1 strain would also provide additional evidence of
potential influences or cerebellar Purkinje cells on PFC DA release in a less exaggerated model
of neurodevelopmental deficiencies within the cerebellum.
Autism Disconnection Hypothesis
The autism disconnection hypothesis states that there is some form of a division in the
autistic brain due to cerebellar neuropathology and more specifically due to a reduction in or
function of Purkinje cells. Studies done by Rogers and colleagues were able to successfully map
various pathways and determine the relative influence and disconnections of specific nuclei
along observed pathways in the Fmr1 and Lurcher strains (2011, 2013a). The study in Chapter 3
did not present any significant differences between the wildtype and mutant strains in any
studied nuclei, however DA release following DN stimulation is novel in itself that allows one to
further explore the potential of any back propagation or feedback system along the nigrostriatal
or mesolimbic pathways. The study in Chapter 4 explored these observed nuclei to see if any
modulatory effects were occurring to compensate for any potential disconnections; two
modulatory shifts were found in the VTA, increased DA release in the mutant, and the ThN md,
increased DA release in the wildtype. In congruence with the autism disconnection hypothesis,
the present studies show cerebellar modulatory effects that extend within and beyond the
mesocortical DA pathway due to cerebellar dysfunction and dysregulation in the autistic brain.
Cerebellar dysfunction or dysregulation lend evidence that the ASDs brain has a variety of
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attenuations and or disconnections likely causing the symptomatology of ASDs. Ultimately
presenting target sites for therapeutic efforts to counteract the effects of cerebellar modulation in
individuals with ASDs.
The need for further understanding ASDs is becoming more salient with every media
campaign, every release of incidence and prevalence rates, and every experimental study much
like the ones described here. The influence of abnormal development, particularly with regards
to cognitions originating in the cerebellum, lend overwhelming evidence that ASDs are in part a
disease of the cerebellum. Experimental research is ascribing evidence of the systemic influence
of the cerebellum on the brain with regards to an array of psychiatric disorders. There is evidence
of influence well beyond the traditional movement and motor influences the cerebellum was
primarily thought to be responsible for. There is still much more to be understood about ASDs,
however the research presented here is another contribution to the mystery that may someday
lead to effective therapeutic efforts to combat the multifaceted effects of ASDs.

79

References
Barnett JH, Robbins TW, Leeson VC, Sahakian BJ, Joyce EM, Blackwell AD. Assessing
cognitive function in clinical trials of schizophrenia. Neurosci Biobehav Rev. 2010;
34(8):1161-77.
Bauman ML. Microscopic neuroanatomic abnormalities in autism. Pediatrics. 1991; 87:791-96.
Centers for Disease Control and Prevention. 2014. MMWR surveillance summary:
Prevalence of autism spectrum disorders among children aged 8 years- Autism and
Developmental Disabilities Monitoring Network. Retrieved from:
http://www.cdc.gov/mmwr/volumes/65/ss/ss6503a1.htm
Courchesne E. Brainstem,cerebellar and limbic neuroanatomical abnormalities in autism. Curr
Opin Neurobio. 1997; 7:269-78.
Courchesne E, Saitoh O, Yeung-Corchesne R, Press GA, Lincoln AJ, Haas RH, Schreibman L.
Abnormality of cerebellar vermian lobules VI and VII in patients with infantile autism:
Identification of hypoplastic and hyperplastic subgroups by MR imaging. Am J
Roentgenology. 1994; 162:123-30.
Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL. Hypoplasia of
cerebellar vermal lobules VI and VII in autism. N Engl J Med. 1988; 318:1349-54.
Da Cunha C, Gomez-A A, Blaha CD. The role of the basal ganglia in motivated behavior.
Reviews in Neuroscience (Special Issue on The emotional brain and its relation to
psychopathology (Editor-in-Chief: Joseph Huston; Guest Editors: Patrizia Campolongo,
Antonella Gasbarri and Carlos Tomaz). 2012; 23(5-6):747-67.

80

DiCicco-Bloom E, Lord C, Zwaigenbaum L, Courchesne E, Dager SR, Schmitz C, et al. The
developmental neurobiology of autism spectrum disorder. J Neurosci. 2006; 26:6897906.
Eagle DM, Wong JCK, Allan ME, Mar AC, Theobald DE, Robbins TW. Contrasting roles
for dopamine D1- and D2-receptor subtypes in the dorsomedial striatum but not the
nucleus accumbens core during behavioral inhibition in the stop-signal task in rats. J
Neurosci. 2011; 31(20):7349-56.
Fatemi SH, Folsom TD. GABA receptor subunit distribution and FMRP-mGluR5 signaling
abnormaities in the cerebellum of subjects with schizophrenia, modd disorders, and
autism. Schizophr Res. 2015; 167(1-3):42-56.
Gauggel S, Rieger M, Feghoff TA. Inhibition of ongoing responses in patients with
Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2004; 75:539-44.
Graybiel, A. M., Aosaki, T., Flaherty, A. W., Kimura, M. The basal ganglia and adaptive motor
control. Science. 1994; 265(5180):1826-31.
Kana RK, Keller TA, Minshew NJ, Just MA. Inhibitory control in high functioning autism:
decreased activation and underconnectivity in inhibition networks. Biological Psychiatry.
2007; 62:198-206.
Koob GF, Volkow ND. Neurocircuitry of addiction. Neuropsychopharmacology. 2010;
35(1):217-38.
Kravitz AV, Tye, LD, Kreitzer AC. Distinct roles for direct and indirect pathway striatal
neurons in reinforcement. Nature Neuroscience. 2012; 15(6):816-18.

81

McKimm E, Corkill B, Goldowitz D, Albritton LM, Homayouni R., Blaha CD, Mittleman G.
Glutamate dysfunction associated with developmental cerebellar damage: relevance to
autism spectrum disorders. Cerebellum. 2014’ 13(3):346-56.
Palmen SJ, van Engeland H, Hof PR, Schmitz C. Neuropathological findings in autism. Brain.
2004; 127:2572-83.
Rogers TD, Dickson PE, Heck DH, Goldowitz D, Mittleman G, Blaha CD. Connecting the
dots of the cerebro-cerebellar role in cognitive function: neuronal pathways for cerebellar
modulation of dopamine release in the prefrontal cortex. Synapse. 2011; 65:1204-12.
Rogers TD, Dickson PE, McKimm E, Heck DH, Goldowitz D, Blaha CD, Mittleman G.
Reorganization of circuits underlying cerebellar modulation of prefrontal cortical
dopamine in mouse models of autism spectrum disorder. Cerebellum. 2013a; 12(4):54756.
Rogers TD, McKimm E, Dickson PE, Goldowitz D, Blaha CD, Mittleman G. Is autism a disease
of the cerebellum? An integration of clinical and pre-clinical research. Front Syst
Neurosci. 2013b; 7:15.
Schultz W. Reward functions of the basal ganglia. J Neural Transm (Vienna). 2016; 124(7):67993.
Shakiba A. The role of the cerebellum in neurobiology of psychiatric disorders. Neurol Clin.
2014; 32(4):1105-15.
Wang SS, Kloth AD, Badura A. The cerebellum, sensitive periods, and autism. Neuron. 2014;
6;83(3):518-32.

82

Whitney ER, Kemper TL, Bauman ML, Rosene DL, Blatt GJ. Cerebellar Purkinje cells are
reduced in a subpopulation of autistic brains: A stereologic experiment using calbindinD28k. Cerebellum. 2008; 7:406-16.

83

APPENDIX

IACUC PROTOCOL ACTION FORM
To:

Chuck Blaha, Deranda Lester (St. Jude)

From

Institutional Animal Care and Use Committee

Subject

Animal Research Protocol

Date

9-15-11

The institutional Animal Care and Use Committee (IACUC) 0701(DA and Parkinson's disease)
has taken the following action
concerning your Animal Research Protocol No.

Your proposal is approved for the following period:
From:

September 15, 2011

To:

September 14, 2014

Your protocol is not approved for the following reasons (see attached memo).

Your protocol is renewed without changes for the following period:
From:

To:

Your protocol is renewed with the changes described in your IACUC Animal
Research Protocol Revision Memorandum dated
for the following period:
From:

To:

Your protocol is not renewed and the animals have been properly disposed of as described
in your IACUC Animal Research Protocol Revision Memorandum dated.
84

Prof. Guy Mittleman, Chair of the IACUC

Dr. Karyl Buddington, University Veterinarian
and Director of the Animal Care Facilities

85

